comparemela.com

Page 9 - Mark Kinarney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary

United statesNew jerseyTim batemanDebbie levenFrancois tranquartMark kinarneyCenters for diseaseGlobal head of clinical developmentCorporate communicationsLantheus holdings incAmerican society of nuclear cardiologyGe healthcareCoronary artery diseasePerfusion imagingMolecular imagingAmerican society

Lantheus to Present at the Wells Fargo Healthcare Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New jerseyUnited statesNorth billericaBob marshallPaul blanchfieldMark kinarneyCorporate communicationsLantheus holdings incChief financial officerChief operating officerWells fargo healthcare conferenceInvestor relationsGlobe newswire

Lantheus Holdings, Inc (LNTH) CEO Mary Heino on Q2 2022 Results - Earnings Call Transcript

Lantheus Holdings, Inc. (NASDAQ:NASDAQ:LNTH) Q2 2022 Earnings Conference Call Aug 4, 2022 8:08 AM Company Participants Mark Kinarney - Senior Director, Investor Relations Mary Heino -.

New yorkUnited statesDistrict of columbiaWest virginiaRadiopharm theranosticsRichard newitterLos angelesMary anneRobert marshallBob marshallNicholas nickolsMary anne heinoE david crawfordRoanna ruizMark kinarneyZachary weiner

Lantheus Hosts Inaugural Investor Day

Lantheus Outlines Sustainable and Profitable Growth Strategy; Introduces Long-Term Financial TargetsNORTH BILLERICA, M.

New jerseyUnited statesNorth billericaMary anne heinoMark kinarneyBausch health companies incExchange commissionLantheus medical imaging incProgenics pharmaceuticals incCorporate communicationsSecurities exchangeLantheus holdings incLantheus outlines sustainableProfitable growth strategyIntroduces long term financialInaugural investor day

Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological Association (AUA) Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesNew jerseyNorth billericaNicholasg nickolsMark kinarneyBausch health companies incProgenics pharmaceuticals incExchange commissionLantheus medical imaging incCorporate communicationsSecurities exchangeLantheus holdings incAmerican cancer societyAssociate professorRadiation oncologyJean claude provost

vimarsana © 2020. All Rights Reserved.